Japanese scientists have made a significant breakthrough using CRISPR gene-editing to remove the extra chromosome responsible for Down syndrome in human cells, but this is an early-stage laboratory development, not a fixed or complete solution.
Misleading
Japan fixed the solution to Down syndrome
Japanese scientists have developed a method for removing the chromosome associated with Down syndrome - MedTour
Source: medtour.help
At a glance
Verified August 4, 2025Key Evidence
Scientists at Mie University successfully used CRISPR to remove the extra chromosome 21 in human cells.
tbsnews.nettbsnews.netJapanese scientists delete extra chromosome behind Down syndrome using CRISPR
japaninsides.comjapaninsides.comJapanese Scientists Remove Extra Chromosome Causing Down Syndrome With CRISPR
The research is currently limited to laboratory settings and has not yet resulted in a clinical treatment.
report.azreport.azScientists make breakthrough in down syndrome treatment in Japan
qazinform.comqazinform.comCould Down syndrome be eliminated? Japanese scientists use CRISPR to target...
Media reports emphasize this as a breakthrough or potential future treatment rather than a completed cure.
medtour.helpmedtour.helpJapanese scientists have developed a method for removing the chromosome...
propakistani.pkpropakistani.pkJapanese Scientists Use CRISPR to Remove Extra Chromosome in Down Syndrome Cells
The reporting
What the Evidence Shows
Recent research led by scientists at Mie University in Japan has demonstrated the use of CRISPR technology to selectively remove the extra copy of chromosome 21, which causes Down syndrome. This represents a major scientific advancement in understanding and potentially treating the genetic basis of the condition.
However, these experiments have so far been conducted in laboratory-grown human cells and have not yet translated into a clinical treatment or cure for individuals with Down syndrome. The term 'fixed the solution' implies a finalized, widely available cure or treatment, which is not accurate at this stage. The research is promising but remains in early experimental phases requiring further validation, safety testing, and clinical trials before any practical medical application can be realized.
Primary trail
Verified Sources7
Open source